Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Filter Content:
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Articles
Interventional Cardiology
8th July 2016
Bioresorbable Vascular Scaffolds as Optimal Treatment for Selected Patients in our Clinical Practice
Bioresorbable vascular scaffolds (BRS)/bioabsorbable stents are a new and promising generation of intravascular devices that may potentially circumvent…
Nephrology
5th July 2016
Editor’s Pick: Targeted Agents in Patients with Metastatic Renal Cell Carcinoma on Dialysis: Myths and Reality
Agents targeting the vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR) pathway, as well as mammalian target of rapamycin (mTOR) inhibitors…
Nephrology
5th July 2016
Uric Acid in Chronic Kidney Disease: A Clinical Appraisal
A consistent body of evidence supports an independent association between uric acid (UA) level and the risk of chronic kidney disease (CKD) in humans.
Nephrology
5th July 2016
Vascular and Valvular Calcifications in Chronic Kidney Disease: An Update
In chronic kidney disease (CKD) and end-stage renal disease patients cardiovascular disease is the main cause of morbidity and mortality, with incidence…
Nephrology
5th July 2016
Tubular Handling of Uric Acid and Factors Influencing Its Renal Excretion: A Short Review
In this review, the authors briefly examine the most recent evidence concerning the role of several proteins involved in tubular urate transport.
Nephrology
5th July 2016
Treating the Diabetic Hypertensive: Consensus and Differences
Hypertension and diabetes commonly coexist. Both are major modifiable risk factors for cardiovascular diseases.
Nephrology
5th July 2016
Automatic Reporting of Creatinine-Based Estimated Glomerular Filtration Rate in Children: Is this Feasible?
Creatinine, although widely used as a biomarker to measure renal function, has long been known as an insensitive marker of renal impairment.
Nephrology
5th July 2016
Fractional Excretion of Survivin, Extracellular Matrix Metalloproteinase Inducer, and Matrix Metalloproteinase 7 in Children with Chronic Kidney Disease
Epithelial–mesenchymal transition (EMT) is defined as a transformation of tubular epithelial cells into mesenchymal ones.
Loading posts...
« Previous
1
…
183
184
185
186
187
…
245
Next »